Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Brief Version (N/A)
Appendix C: Acronyms
Last Updated: October 26, 2016; Last Reviewed: October 26, 2016
Acronym/Abbreviation | Full Name |
---|---|
3TC | lamivudine |
ABC | abacavir |
ACOG | American College of Obstetricians and Gynecologists |
ALT | alanine aminotransferase |
anti-HBc | anti-hepatitis B core antibody |
anti-HBS | hepatitis B surface antibody |
AOR | adjusted odds ratio |
AP | antepartum |
ART | antiretroviral therapy |
ARV | antiretroviral |
AST | aspartate aminotransferase |
ATV | atazanavir |
ATV/r | atazanavir/ritonavir |
AUC | area under the curve |
AZT | zidovudine |
BID | twice daily |
BMI | body mass index |
CBC | complete blood count |
CD4 | CD4 T lymphocyte |
CDC | Centers for Disease Control and Prevention |
CI | confidence interval |
Cmax | maximum plasma concentration |
Cmin | minimum plasma concentration |
CNS | central nervous system |
COBI | cobicistat |
CVS | chorionic villus sampling |
CYP | cytochrome P |
CYP3A4 | cytochrome P450 3A4 |
d4T | stavudine |
ddI | didanosine |
DMPA | depot medroxyprogesterone acetate |
DRV | darunavir |
DRV/r | darunavir/ritonavir |
DSMB | Data and Safety Monitoring Board |
DTG | dolutegravir |
EC | enteric coated |
ECG | electrocardiogram |
EFV | efavirenz |
EMS | ethyl methane sulfonate |
ETR | etravirine |
EVG | elvitegravir |
FDA | Food and Drug Administration |
FDC | fixed drug combination |
FPV | fosamprenavir |
FPV/r | fosamprenavir/ritonavir |
FTC | emtricitabine |
gp | glycoprotein |
HAV | hepatitis A virus |
HBIG | hepatitis B immune globulin |
HBsAg | hepatitis B surface antigen |
HBV | hepatitis B virus |
HCV | hepatitis C virus |
HELLP | hemolysis, elevated liver enzymes, and low platelets |
HGC | hard gel capsule |
HR | hazard ratio |
HRSA | Health Resources and Services Administration |
HSR | hypersensitivity reaction |
IC50 | inhibitory concentration 50% |
IDV |
indinavir |
IDV/r | indinavir/ritonavir |
IGF |
insulin-like growth factor |
IgG | Immunoglobulin G |
IP |
intrapartum |
IQR |
interquartile range |
IRIS |
immune reconstitution inflammatory syndrome |
IUD |
intrauterine device |
IV |
intravenous/intravenously |
LPV |
lopinavir |
LPV/r |
lopinavir/ritonavir |
MAC |
Mycobacterium avium complex |
mtDNA | mitochondrial DNA |
MVC | maraviroc |
NFV | nelfinavir |
NIH | National Institutes of Health |
NNRTI | non-nucleoside reverse transcriptase inhibitor/non-nucleoside analogue reverse transcriptase inhibitor |
NRTI | nucleoside reverse transcriptase inhibitor/nucleoside analogue reverse transcriptase inhibitor |
NtRTI | nucleotide analogue reverse transcriptase inhibitor |
NVP | nevirapine |
OC | oral contraceptive |
OI | opportunistic infection |
OR | odds ratio |
The Panel | The Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission |
PCP | Pneumocystis jirovecii pneumonia |
PCR | polymerase chain reaction |
PI | protease inhibitor |
PK | pharmacokinetic |
PO | orally |
PP |
postpartum
|
PPI | proton pump inhibitor |
PrEP | pre-exposure prophylaxis |
PTD | preterm delivery |
RAL | raltegravir |
RDS | respiratory distress syndrome |
RPV | rilpivirine |
RR | relative risk |
RTV |
ritonavir |
SD |
single dose |
SQ |
subcutaneous |
SQV |
saquinavir |
SQV/r |
saquinavir/ritonavir |
STD |
sexually transmitted disease |
T20 | enfuvirtide |
TAF | tenofovir alafenamide |
TDF |
tenofovir disoproxil fumarate |
TDM | therapeutic drug monitoring |
TID |
three times daily |
TPV |
tipranavir |
TPV/r |
tipranavir/ritonavir |
UGT |
uridine diphosphate glucuronosyltransferase |
WHO |
World Health Organization |
ZDV |
zidovudine |
Download Guidelines
- Section Only PDF (745 KB)
- Full Guideline PDF ()
- Recommendations Only PDF (211 KB)
- Tables Only PDF (388 KB)
Related Content
- AIDSinfo Drug Database
- AIDSinfo Patient Materials: Preventing Mother-to-Child Transmission of HIV
- AIDSinfo Patient Materials: HIV Medicines During Pregnancy and Childbirth
- AIDSinfo Patient Materials: Protecting Baby from HIV
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Perinatal Guidelines Archive